Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790M

Bibliographic Details
Published in:Global Medical Genetics
Main Author: Xiaoying Zhang
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2021-06-01
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731067
_version_ 1849753845268217856
author Xiaoying Zhang
author_facet Xiaoying Zhang
author_sort Xiaoying Zhang
collection DOAJ
container_title Global Medical Genetics
format Article
id doaj-art-252b3ac718da4cfca5ef207a3cbd1f8d
institution Directory of Open Access Journals
issn 2699-9404
language English
publishDate 2021-06-01
publisher KeAi Communications Co., Ltd.
record_format Article
spelling doaj-art-252b3ac718da4cfca5ef207a3cbd1f8d2025-08-20T01:37:24ZengKeAi Communications Co., Ltd.Global Medical Genetics2699-94042021-06-01080413313410.1055/s-0041-1731067Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790MXiaoying Zhang0Department of Geriatrics, Qilu Hospital of Shandong University, Jinan, People's Republic of Chinahttp://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731067
spellingShingle Xiaoying Zhang
Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790M
title Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790M
title_full Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790M
title_fullStr Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790M
title_full_unstemmed Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790M
title_short Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790M
title_sort osimertinib in combination with bevacizumab fails in advanced lung adenocarcinoma harboring egfr t790m
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731067
work_keys_str_mv AT xiaoyingzhang osimertinibincombinationwithbevacizumabfailsinadvancedlungadenocarcinomaharboringegfrt790m